copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
5 New Medical Breakthroughs for COPD Patients - WebMD Researchers are working on new therapies to treat the symptoms of chronic obstructive pulmonary disease (COPD), like shortness of breath, lung inflammation, and chronic cough Some are already
A New Treatment for Chronic Obstructive Pulmonary Disease . . . Chronic obstructive pulmonary disease (COPD) pharmacological therapy has advanced in recent years Combining long-acting bronchodilators and inhaled corticosteroids (ICSs) as a single-inhaler triple therapy reduces mortality in patients with COPD at high exacerbation risk (1, 2)
Promising cure for COPD: Is a breakthrough treatment within . . . Looking ahead, the researchers are now planning a phase 2 trial of the treatment, which will evaluate its efficacy in a larger group of patients The trial has been approved by China’s National Medical Products Administration (NMPA), the Chinese equivalent of the U S Food and Drugs Administration (FDA) A promising future for COPD treatment
Advances in Chronic Obstructive Pulmonary Disease - PMC Late breaking abstract—first-in-human results of bronchial rheoplasty: an endobronchial treatment for chronic bronchitis (CB) Eur Respir J 52:OA2162 (Abstr ) [Google Scholar] 84 Siddiqui FM, Diamond JM 2018 Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions Curr Opin Pulm
New Therapies in Outpatient Pulmonary Medicine - PubMed Treatment advances have led to improved outcomes for patients with asthma, chronic obstructive pulmonary dise … Newer medications and devices, as well as greater understanding of the benefits and limitations of existing treatments, have led to expanded treatment options for patients with lung disease
FDA Approves GSK’s Nucala for Chronic Obstructive Pulmonary . . . Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells μL The FDA has approved GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease
New frontiers in the treatment of COPD - Mayo Clinic Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterized by shortness of breath, cough and sputum production due to both airway and parenchymal lung damage "It is increasingly recognized that patients with COPD have different phenotypes, and treatment can be tailored
Whats New in COPD Treatment? - Verywell Health There are two types of COPD: emphysema and chronic bronchitis Emphysema is a condition that damages the air sacs of the lungs, making it harder to breathe Chronic bronchitis causes long-term inflammation of the airways, leading to a persistent wet cough that produces thick mucus Many people with COPD have both conditions at the same time